Bioquark Inc.

The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe.

Bioquark Inc. and RegenerAge SAPI de CV will focus on translational therapeutic applications of a range of regenerative and rejuvenation based healthcare interventions, with the goal of reducing human degeneration, suffering, and death.

The Reanima Project - Is Death Reversible? - IRB Approval for First-In-Human Brain Death Study

Focusing On Biologically Reversing Paralysis And Getting Patients Walking and Out Of Wheelchairs